Crossing the blood-brain barrier: Clinical interactions between neurologists and hematologists in pediatrics - Advances in childhood arterial ischemic stroke and cerebral venous thrombosis

Current Opinion in Pediatrics

Volumn 22, Issue 1, 2010, Pages 20-27

  Witmer, Char ^a   Ichord, Rebecca ^a,b  

^a Department Pediatrics ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antithrombotic treatment; Magnetic resonance imaging; Prothrombotic condition; Recurrence; Vasculopathy

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BLOOD BRAIN BARRIER; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; FIBRINOLYTIC THERAPY; HEMATOLOGIC DISEASE; HUMAN; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA;

BLOOD COAGULATION DISORDERS; BRAIN ISCHEMIA; CHILD; DIAGNOSTIC IMAGING; HEMATOLOGY; HUMANS; INTERDISCIPLINARY COMMUNICATION; NEUROLOGY; PATIENT CARE TEAM; PEDIATRICS; RECURRENCE; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; STROKE;

EID: 75749129528     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283350d94     Document Type: Review

References (52)

1. Chan AK, deVeber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost 2003; 1:1443-1455.
2. Barron TF, Gusnard DA, Zimmerman RA, et al. Cerebral venous thrombosis in neonates and children. Pediatr Neurol 1992; 8:112-116.
3. deVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345:417-423.
4. Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128:477-489.
5. Carvalho KS, Bodensteiner JB, Connolly PJ, et al. Cerebral venous thrombosis in children. J Child Neurol 2001; 16:574-580.
6. Golomb MR, Fullerton HJ, Nowak-Gottl U, et al. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 2009; 40:52-57.
7. Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108:1362-1367.
8. WasayM, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol 2008; 23:26-31.
9. Kenet G, Waldman D, Lubetsky A, et al. Paediatric cerebral sinus vein thrombosis. A multicenter, case-controlled study. Thromb Haemost 2004; 92:713-718.
10. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644-2691.
11. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2008; 133:887S-968S.
12. Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27:1724-1730.
13. Wysokinska EM, Wysokinski WE, Brown RD, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008; 70:627-633.
14. Kenet G, Kirkham F, Niederstadt T, et al. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol 2007; 6:595-603.
15. Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clin Radiol 2002; 57:449-461.
16. Linn J, Pfefferkorn T, Ivanicova K, et al. Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol 2009; 30:728-735.
17. Bianchi D, Maeder P, Bogousslavsky J, et al. Diagnosis of cerebral venous thrombosis with routine magnetic resonance: an update. Eur Neurol 1998; 40:179-190.
18. Dormont D, Anxionnat R, Evrard S, et al. MRI in cerebral venous thrombosis. J Neuroradiol 1994; 21:81-99.
19. Nwosu ME, Williams LS, Edwards-Brown M, et al. Neonatal sinovenous thrombosis: presentation and association with imaging. Pediatr Neurol 2008; 39:155-161.
20. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338:597-600.
21. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30:484-488.
22. deVeber G, Chan A, Monagle P, et al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998; 55:1533-1537.
23. Wasay M, Bakshi R, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 2001; 32:2310-2317.
24. Griesemer DA, Theodorou AA, Berg RA, et al. Local fibrinolysis in cerebral venous thrombosis. Pediatr Neurol 1994; 10:78-80.
25. Liebetrau M, Mayer TE, Bruning R, et al. Intra-arterial thrombolysis of complete deep cerebral venous thrombosis. Neurology 2004; 63:2444-2445.
26. Soleau SW, Schmidt R, Stevens S, et al. Extensive experience with dural sinus thrombosis. Neurosurgery 2003; 52:534-544.
27. De Schryver EL, Blom I, Braun KP, et al. Long-term prognosis of cerebral venous sinus thrombosis in childhood. Dev Med Child Neurol 2004; 46:514-519.
28. Fullerton HJ, Wu YW, Zhao S, et al. Risk of stroke in children: ethnic and gender disparities. Neurology 2003; 61:189-194.
29. Giroud M, Lemesle M, Gouyon JB, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995; 48:1343-1348.
30. Nowak-Gottl U, Langer C, Bergs S, et al. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect 2008; 116:839-843.
31. Raju TN, Nelson KB, Ferriero D, et al. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007; 120:609-616.
32. Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 2009; 40:58-64.
33. Srinivasan J, Miller SP, Phan TG, et al. Delayed recognition of initial stroke in children: need for increased awareness. Pediatrics 2009; 124:e227-e234.
34. deVeber G. Stroke and the child's brain: an overview of epidemiology, syndromes and risk factors. Curr Opin Neurol 2002; 15:133-138.
35. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol 2004; 3:150-158.
36. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53:167-173.
37. Amlie-Lefond C, Bernard TJ, Sebire G, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009; 119:1417-1423.
38. Sebire G, Fullerton H, Riou E, et al. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004; 16:617-622.
39. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res 2006; 118:67-74.
40. Lynch JK, Han CJ, Nee LE, et al. Prothrombotic factors in children with stroke or porencephaly. Pediatrics 2005; 116:447-453.
41. Strater R, Vielhaber H, Kassenbohmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158 (Suppl 3):S122-S125.
42. Simchen MJ, Goldstein G, Lubetsky A, et al. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke 2009; 40:65-70.
43. Haywood S, Liesner R, Pindora S, et al. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child 2005; 90:402-405.
44. Goldenberg NA, Bernard TJ, Fullerton HJ, et al. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009; 8:1120-1127.
45. Ganesan V, Hogan A, Shack N, et al. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol 2000; 42:455-461.
46. deVeber GA, MacGregor D, Curtis R, et al. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000; 15:316-324.
47. Lynch JK, Han CJ. Pediatric stroke: what do we know and what do we need to know? Semin Neurol 2005; 25:410-423.
48. Ganesan V, Prengler M, Wade A, et al. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006; 114:2170-2177.
49. Fullerton HJ, Wu YW, Sidney S, et al. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119:495-501.
50. Bernard TJ, Goldenberg NA, Tripputi M, et al. Anticoagulation in childhoodonset arterial ischemic stroke with nonmoyamoya arteriopathy: findings from the Colorado and German (COAG) collaboration. Stroke 2009; 40:2869-2871.
51. Strater R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002; 360:1540-1545.
52. Sofronas M, Ichord RN, Fullerton HJ, et al. Pediatric stroke initiatives and preliminary studies: what is known and what is needed? Pediatr Neurol 2006; 34:439-445.